Discover 1,803 paid clinical trials in Greensboro, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,803
The Vanguard Study: Testing a New Way to Screen for Cancer
for
Bladder Carcinoma, Breast Carcinoma, Colorectal Carcinoma,
Location: Chapel Hill NC, Durham NC, South Hill VA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 45 - 70+
Code: NCT06995898
Recruiting
PAS 1ml MagtraceĀ® for Sentinel Lymph Node Biopsy in Breast Cancer Patients
for
Breast Cancer
Location: Chapel Hill NC, Richmond VA
Sponsor: Endomagnetics Ltd.
Sex: All
Age: 18+
Code: NCT06610539
Recruiting
Expanding the Support of Family Caregivers of Diverse Patients With Cancer and Diabetes
for
Cancer, Diabetes
Location: Chapel Hill NC, Tampa FL, Burlington VT
Sponsor: UNC Lineberger Comprehensive Cancer Center
Sex: All
Age: 18 - 70+
Code: NCT07061652
Recruiting
Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
for
Smoldering Plasma Cell Myeloma
Location: Chapel Hill NC, Kenansville NC, Kinston NC,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT03937635
Phase3, Recruiting
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Location: Chapel Hill NC, Charlotte NC, Fairfax VA, Bluffton SC,
Sponsor: American Society of Clinical Oncology
Sex: All
Age: 12+
Code: NCT02693535
Phase2, Recruiting
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
for
Refractory Differentiated Thyroid Gland Carcinoma
Location: Chapel Hill NC, Durham NC, Charleston SC, Baltimore MD,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT06475989
Phase3, Recruiting
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Chapel Hill NC, Pinehurst NC, Hendersonville NC,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06589804
Phase3, Recruiting
Screening for AL Amyloidosis in Smoldering Multiple Myeloma
for
Smoldering Multiple Myeloma
Location: Durham NC, Charlotte NC, Richmond VA, Columbus OH,
Sponsor: Tufts Medical Center
Sex: All
Age: 40+
Code: NCT06365060
Recruiting
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Location: Chapel Hill NC, Durham NC, Spartanburg SC, Columbia SC,
Sponsor: ReCor Medical, Inc.
Sex: All
Age: 18+
Code: NCT06297291
Recruiting
BEACON - Phase III Clinical Study of Rugonersen in Angelman Syndrome.
for
Angelman Syndrome
Location: Chapel Hill NC, Chicago IL, San Diego CA
Sponsor: OHB Pediatrics Ltd.
Sex: All
Age: 1 - 50
Code: NCT07605429
Phase3, Recruiting
A U.S. Pilot Human Investigation of RadiofrEquency Vapor Ablation System to Evaluate Safety, TOleRability, and Effectiveness for Proximal Intestinal Mucosal Ablation in Patients With Type 2 Diabetes Mellitus (RESTORE-1 Study)
for
Type-2 Diabetes Mellitus
Location: Chapel Hill NC, Scottsdale AZ, Newport Beach CA